Showing 161 - 180 results of 14,150 for search '(( significant decrease release ) OR ( significantly ((shorter decrease) OR (reported decrease)) ))', query time: 1.20s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170

    Significant change in self-reported behaviour between Pre-Test (T1) to Follow-Up (T3). by Michelle McNab (6984125)

    Published 2019
    “…Significant decrease in the number of sweets consumed per day was identified. c) Instances of tobacco use reported at T1 and T3. …”
  11. 171
  12. 172

    Image_1_Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.TIFF by Shohei Moriyama (6924746)

    Published 2022
    “…On day 8, the pericardial effusion decreased, and the hemodynamic status markedly stabilized. …”
  13. 173

    Image_2_Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.TIFF by Shohei Moriyama (6924746)

    Published 2022
    “…On day 8, the pericardial effusion decreased, and the hemodynamic status markedly stabilized. …”
  14. 174

    Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report by Nashimoto S. (17866511)

    Published 2024
    “…Mycophenolate mofetil (MMF), an inactive prodrug of mycophenolic acid (MPA), is an immunosuppressive drug used widely in the treatment of lupus nephritis. In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180